We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Annual report of the Human Medicines Regulations 2012 Advisory Bodies - the Commission on Human Medicines (CHM) and the British Pharmacopoeia Commission
Information on Medicines and Healthcare products Regulatory Agency spending over £25,000.
Third annual business plan to deliver the Medicines and Healthcare products Regulatory Agency’s Corporate Plan 2018-23
Information on how the 2019 voluntary scheme for branded medicines pricing and access is controlling spend on branded medicines in the NHS.
MHRA transactions over £500 made using the government procurement card (GPC).
Information on how the Pharmaceutical Price Regulation Scheme (PPRS) is controlling spend on branded medicines in the NHS.
The second annual review of the regulations relating to the statutory scheme for branded medicines pricing.
First published during the 2019 to 2022 Johnson Conservative government
Information on how the 2019 Voluntary Scheme for Branded Medicines Pricing and Access is controlling spend on branded medicines in the NHS.
Annual reviews of the Health Service Products (Provision and Disclosure of Information) Regulations 2018 and the Health Service Medicines (Price Control Penalties and Price Control Appeals Amendment) Regulations 2018.
This document contains the MHRA annual report and accounts 2018 to 2019.
The first annual review of the regulations relating to the statutory scheme for branded medicines pricing.
First published during the 2016 to 2019 May Conservative government
How the Pharmaceutical Price Regulation Scheme (PPRS) is controlling spend on branded medicines in the NHS.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).